Public Health Policy: China’s State Council released a new five-year health plan aiming to lift average life expectancy to 80 by 2030, with stronger primary care, disease prevention, emergency response, and smoke-free measures plus smoking-cessation support. Clinical Guidance: A China-led multidisciplinary panel published updated, evidence-based consensus guidance for diagnosing and treating prolactinomas, reflecting advances in surgery, imaging, and medical therapy. Infection Control & Care Quality: ISSA launched the Healthcare Environmental Hygiene Professional Certification, a three-tier training program meant to standardize hospital cleaning and disinfection practices to help curb healthcare-associated infections and antimicrobial resistance. AI Drug Discovery: Insilico Medicine and China Medical System announced a second AI-driven CNS drug discovery deal, with milestone payments up to about RMB 1.2 billion, targeting a mass-market brain-disease indication. Rare Disease R&D: Niagen Bioscience received U.S. FDA rare pediatric disease designation and Europe’s orphan medicinal product designation for NB4168 in ataxia telangiectasia. Food Safety Concern: A systematic review reported pesticide residues in infant formula across multiple countries, raising short- and long-term health concerns for babies. Disaster Response: China’s agriculture ministry sent flood relief supplies and experts to Guangxi to protect livestock health and support agricultural recovery after typhoon flooding. Health & Wellness Lifestyle: A popular expert opinion piece highlights ginger and elderberries as complementary “superfoods,” while another column discusses potential longevity links from regular spicy food intake.